Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin. (Q40458621)

20 September 2017

Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin. (English)

1 reference

20 September 2017

0 references

1 reference

4

Melvin H Freedman

1 reference

20 September 2017

Hooman Ganjavi

1

1 reference

20 September 2017

Matthew Gee

series ordinal

2

1 reference

20 September 2017

Aru Narendran

series ordinal

3

1 reference

20 September 2017

David Malkin

series ordinal

5

1 reference

20 September 2017

1 April 2005

1 reference

20 September 2017

1 reference

20 September 2017

12

1 reference

20 September 2017

4

1 reference

20 September 2017

397-406

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700798

20 September 2017

0 references

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Update on childhood rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children's oncology group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Oncogenes in solid human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

N-ras gene activation in the RD human rhabdomyosarcoma cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Metastatic rhabdomyosarcoma and histologically similar tumors in childhood: a retrospective European multi-center analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Disease patterns and survival rate in children with metastatic soft-tissue sarcoma. A report from the Intergroup Rhabdomyosarcoma Study (IRS)-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Immunostaining of the p30/32MIC2 antigen and molecular detection of EWS rearrangements for the diagnosis of Ewing's sarcoma and peripheral neuroectodermal tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Ewing sarcoma family of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Ewing's sarcoma: presentation and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Gene rearrangements in Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Unusual presentation of Ewing sarcoma with t(21;22) in a 3-year-old boy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Overexpression of p53 protein in primary Ewing's sarcoma of bone: relationship to tumour stage, response and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Ewing's sarcoma of bone. Experience with 140 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Common musculoskeletal tumors of childhood and adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Ad5CMVp53 gene therapy for locally advanced prostate cancer--where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Clinical update of Ad-p53 gene therapy for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Novel gene therapy approach for nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Restoration of p53 function in anaplastic Wilms' tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Selective chemosensitization of rhabdomyosarcoma cell lines following wild-type p53 adenoviral transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Expression of the coxsackievirus and adenovirus receptor in musculoskeletal tumors and mesenchymal tissues: efficacy of adenoviral gene therapy for osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Effects of styrene-7,8-oxide over p53, p21, bcl-2 and bax expression in human lymphocyte cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Down-regulation of the DNA-repair endonuclease 8-oxo-guanine DNA glycosylase 1 (hOGG1) by sodium dichromate in cultured human A549 lung carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Tp53 gene therapy: a key to modulating resistance to anticancer therapies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Mutations in the p53 gene occur in diverse human tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Tumor spectrum analysis in p53-mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Germline TP53 mutations and Li-Fraumeni syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Phase I study of a recombinant adenovirus-mediated gene transfer in lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Intravascular adenoviral agents in cancer patients: lessons from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Dependence of efficient adenoviral gene delivery in malignant glioma cells on the expression levels of the Coxsackievirus and adenovirus receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Efficiency of adenovirus-mediated gene transfer to oropharyngeal epithelial cells correlates with cellular differentiation and human coxsackie and adenovirus receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Role of integrin expression in adenovirus-mediated gene delivery to the intestinal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

The levels of integrin alpha v beta 5 may predict the susceptibility to adenovirus-mediated gene transfer in human lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Efficient adenoviral-mediated murine neonatal small intestinal gene transfer is dependent on alpha(v) integrin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

The Ewing Family of Tumors -- A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

Undifferentiated sarcomas of children: pathology and clinical behavior--an Intergroup Rhabdomyosarcoma study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

7 January 2021

Prognostic impact of P53 status in Ewing sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

7 January 2021

Molecular analysis of the 9p21 locus and p53 genes in Ewing family tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

7 January 2021

Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study IESS-II

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

7 January 2021

Gene therapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

7 January 2021

Quercetin: synergistic action with carboxyamidotriazole in human breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

7 January 2021

A high easy-to-treat complication rate is the price for continent stoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

7 January 2021

Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700798

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700798

1 reference

Dimensions Publication ID

20 September 2017

0 references

1 reference